Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleArticle

Contribution of Matrix Metalloproteinase-1 Genotypes to Colorectal Cancer in Taiwan

MING-HSIEN WU, TE-CHENG YUEH, WEN-SHIN CHANG, CHIA-WEN TSAI, CHUN-KAI FU, MEI-DUE YANG, CHIEN-CHIH YU and DA-TIAN BAU
Cancer Genomics & Proteomics May 2021, 18 (3) 245-251; DOI: https://doi.org/10.21873/cgp.20255
MING-HSIEN WU
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
2Division of Colon and Rectal Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.;
3National Defense Medical Center, Taipei, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TE-CHENG YUEH
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
2Division of Colon and Rectal Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.;
3National Defense Medical Center, Taipei, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WEN-SHIN CHANG
4Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIA-WEN TSAI
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
4Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHUN-KAI FU
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
3National Defense Medical Center, Taipei, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MEI-DUE YANG
4Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIEN-CHIH YU
5School of Pharmacy, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DA-TIAN BAU
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
4Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
6Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: datian@mail.cmuh.org.tw artbau2@gmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Matrix metalloproteinase-1 is responsible for extracellular matrix regulation, and its genetic role in colorectal cancer (CRC) is unclear. The aim of the study was to investigate the contribution of Matrix metalloproteinase-1 genotypes to CRC risk in Taiwan. Materials and Methods: A total of 362 cases and 362 controls were included and their MMP-1 -1607 (rs1799705) genotypes were examined. The environmental factors and clinical-pathological records were also analyzed. Results: The genotypic frequency of MMP-1 rs1799750 were different between the CRC and control groups (p for trend=0.0083). 1G/2G and 1G/1G were associated with lower risk (p=0.0438 and 0.0030, adjusted OR=0.73 and 0.54, 95%CI=0.54-0.90 and 0.37-0.83). Among non-smokers, those with 1G/2G and 1G/1G genotypes were at 0.70- and 0.48-fold odds of having CRC. Among non-alcohol drinkers, people with 1G/2G and 1G/1G genotypes were at 0.71- and 0.54-fold odds. The 1G/1G genotypes were statistically lower among CRC patients with lymph node metastasis (7.2%) than those without (19.0%). Conclusion: The genotypes at MMP-1 rs1799705 play a role in determining susceptibility to CRC risk in Taiwan.

Key Words:
  • Colorectal cancer
  • genotype
  • MMP-1
  • polymorphism
  • Taiwan

Colorectal cancer (CRC), the second most common occurring cancer in females and the third most common cancer in males, it has over 1.8 million new cases in 2018 all over the world (1-3). The incidence and mortality rates of CRC vary by a factor of as high as ten (2-4). From the viewpoint of epidemiology, the environmental factors such as meat consumption, cigarette smoking, and exposure to carcinogens contribute to about 85% of CRC etiology (5, 6). At the same time, at least 15-20% of CRC etiology could be traced with familial cancer history (7, 8). In Taiwan, the incidence rate of CRC is on top of all types of cancer, while the mortality rate of CRC has been listed as the third among all types of cancer. With the efforts of some scientists, specific biomarkers for CRC have been reported within the decade (9-13). However, the interactions between genomic and environmental risk factors still need further investigation.

Matrix metalloproteinases (MMPs), is a family of proteins that degrade extracellular matrix proteins including collagen, laminin, and fibronectin, and so on (14). They also play a critical role in cell proliferation, differentiation, apoptosis, invasion, migration and immune responses (15, 16). In recent years, it has been shown that genotypic variants of MMPs were associated with the susceptibility of several types of cancer (17-20). Among these MMPs, MMP-1 is the first vertebrate collagenase to be purified and cloned, and is encoded by the MMP1 gene (21, 22). The most commonly studied MMP-1 polymorphism is rs1799750, which is located at -1607 of the promoter region. The variants may consist the “2G” insertion polymorphism, which has been reported to lead to higher levels of MMP-1 in the serum, potentially to higher levels of collagen breakdown than the 1G genotype (23). In a meta-analysis, it was concluded that people who have MMP-1 rs1799750 2G/2G genotypes may have a slightly higher metastasis rate (24). As far as CRC is concerned, MMP-1 has been reported to be overexpressed and closely related to poor prognosis (25-27). Based on above clues, we hypothesize that the variant genotypes at the promoter region at MMP-1 rs1799750 may play a role in determining the susceptibility for CRC in Taiwan.

Materials and Methods

Collection of 362 CRC cases and 362 controls. The investigated population has been recruited as described in our previous studies (9-12). Concisely, CRC cases have been recruited at the outpatient clinics of general surgery by well-trained colleagues. The pathological-clinical data of each participant were defined, graded and recorded by experienced doctors. We reselected some of the controls to match well the control and case group by age and gender. All the procedures were approved and supervised by the Institutional Review Board of the China Medical University Hospital (IRB project identification coding number: DMR99-IRB-108).

MMP-1 rs1799750 genotyping methodology. The genomic DNA from peripheral blood leukocytes of all participants were extracted and stored at –80°C as previously published (9, 10). The MMP-1 rs1799750 genotyping methodology is the same as previously reported (17, 19). The polymerase chain reaction (PCR) conditions set for MMP-1 rs1799750 genotyping were one cycle at 94°C for 5 min; 35 cycles at 94°C for 30 sec, one cycle at 57°C for 30 sec and one cycle at 72°C for 30 sec and a final extension at 72°C for 10 min.

Statistical analysis. Pearson’s Chi-square test without Yates’ correction was applied to compare the distribution of MMP-1 genotypic and allelic distributions between CRC and control groups. The associations between the MMP-1 genotypes and CRC risk were estimated by odds ratios (ORs) as well as their 95% confidence intervals (CIs) from logistic regression analysis.

Results

Basic indexes between CRC patient and control groups. The distribution of age and gender for the 362 CRC patients and 362 non-cancer healthy controls is shown and compared in Table I. There were 203 (56.1%) males and 159 (43.6%) females in the CRC group, and we matched the age and gender very well, so there was no significant difference between the two groups as for the frequencies of age or gender (both p>0.05) (Table I). As for the personal habits, 91 (25.1%) of the CRC group had smoking habits, while 44 (12.2%) had alcohol drinking habits. They were not significantly different from those of the control group (23.2% had smoking and 14.1% had alcohol drinking habit, respectively) (Table I). The control group had 51.7% people with BMI ≥24, while case group had 46.7% (p=0.1809) (Table I).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Summary of selected data from 362 patients with colorectal cancer and 362 matched non-cancer healthy controls.

Association analysis of MMP-1 rs1799750 genotypes with CRC risk. The genotyping pattern of MMP-1 rs1799750 among the CRC and control groups are shown in Table II. First, the genotypic frequency distribution pattern of MMP-1 rs1799750 were different between the CRC and control groups (p for trend=0.0083) (Table II). In detail, the MMP-1 rs1799750 heterozygous 1G/2G and homozygous 1G/1G variant genotypes were associated with lower risk for colorectal cancer than the wild-type 2G/2G genotype (p=0.0438 and 0.0030, adjusted OR=0.73 and 0.54, 95%CI=0.54-0.90 and 0.37-0.83) (Table II). In the recessive model, the 1G/1G genotype at MMP-1 rs1799750 conferred a decreased risk for CRC compared to combination of 2G/2G and 1G/2G genotypes (2G/2G+1G/2G) (p=0.0186, adjusted OR=0.65, 95%CI=0.48-0.94) (Table II). In the dominant model, those who carry 1G/1G+1G/2G at MMP-1 rs1799750 conferred a decreased susceptibility of CRC compared to the 2G/2G genotype carriers (p=0.0061, adjusted OR=0.62 and 95%CI=0.42-0.81, Table II). Overall, the MMP-1 rs1799750 genotypes play a critical role in determining personal susceptibility to CRC in Taiwan.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Distribution of matrix metalloproteinase-1 rs1799750 genotypic frequencies among the colorectal cancer patients and healthy controls.

Association analysis of MMP-1 rs1799750 allelic frequencies with CRC risk. The allelic frequency analysis of MMP-1 rs1799750 with CRC risk was performed and is presented in Table II. Consistent with the major finding in Table II, there is an obvious difference in the distribution of allelic frequencies between the CRC and healthy control groups regarding MMP-1 rs1799750 (Table III). In detail, those subjects carrying 1G allele at MMP-1 rs1799750 were lower in the CRC group (34.9%) than those in the control group (43.2%) (adjusted OR=0.73, 95%CI=0.52-0.81, p=0.0012) (Table III).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Allelic frequencies for matrix metalloproteinase-1 rs1799750 polymorphisms among colorectal cancer patients and healthy controls.

Interaction of personal habits with MMP-1 rs1799750 genotype on CRC risk. Since cigarrete smoking and alcohol drinking habits serve as risk factors for CRC in Taiwan, we were interested to examine the interactions between the genotype of MMP-1 rs1799750 with personal cigarette smoking and alcohol drinking status. Firstly, among non-smokers, those with MMP-1 rs1799750 1G/2G and 1G/1G genotypes were at 0.70- and 0.48-fold odds of having CRC (95%CI=0.48-1.01 and 0.29-0.78, p=0.0551 and 0.0027, respectively), while there was no synergistic or additive effect observed among the smokers (Table IV). After adjusting for age, gender, alcohol drinking and BMI status, the statistical significance still existed for the homozygous 1G/1G (adjusted OR=0.45, 95%CI=0.27-0.75) (Table IV). Secondly, among non-alcohol drinkers, people with MMP-1 rs1799750 1G/2G and 1G/1G genotypes were at 0.71- and 0.54-fold odds of having CRC (95%CI=0.50-1.00 and 0.34-0.85, p=0.0501 and 0.0080, respectively), while there was no synergistic or additive effect observed among alcohol drinkers (Table V). After adjusting for age, gender, cigarrete smoking and BMI status, the statistical significance still existed for the homozygous 1G/1G (adjusted OR=0.51, 95%CI=0.31-0.81, Table V).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Odds ratio for matrix metalloproteinase-1 rs1799750 genotype and colorectal cancer after stratification by smoking status.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table V.

Odds ratios for matrix metalloproteinase-1 rs1799750 genotype and colorectal cancer after stratification by alcohol drinking status.

Correlation between genotypes of MMP-1 rs1799750 and clinicopathological features. The correlations between genotypes of MMP-1 rs1799750 and clinicopathological features among the 362 CRC patients were analyzed and the results are shown in Table VI. No statistically significant correlation was observed between A MMP-1 rs1799750 genotypic distributions and age, gender, BMI, tumor size or location (all p>0.05) (Table VI). Interestingly, the percentages of 1G/1G genotype of MMP-1 rs1799750 were statistically lower among the CRC patients with lymph node metastasis (7.2%) than those without lymph node involvement (19.0%, p=0.0052) (Table VI).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table VI.

Correlation between matrix metalloproteinase-1 rs1799750 genotypes and clinicopathological properties of 362 colorectal cancer patients.

Discussion

MMPs play a critical role in the metabolism of extracellular matrix components, and any imbalance of the extracellular microenvironment may be related to initiation and progression of cancer. MMP-1 specifically breaks down the interstitial collagens, type I, II, III, VI and X. It is such an essential protein that no knockout murine studies are available so far. Revealing the association of MMP-1 genotypes with CRC risk will not only advance our understanding of the mechanisms underlying tumorigenesis, but also facilitate the improvement of novel therapeutics.

The positive association of MMP-1 rs1799750 genotypes with CRC risk (Tables II and III) is consistent with previous reports in childhood leukemia (28), gastric cancer (29) nasopharyngeal carcinoma (30) and pterygium (19). In a meta-analysis investigating more than 38,000 subjects, the results also indicated that the genotypes of MMP-1 rs1799750 may be associated with colorectal, head and neck and renal cancer risk (31). However, in other types of cancers, the genotypes of MMP-1 rs1799750 may not directly contribute to susceptibility determination (17, 32-35), which indicated that the MMP-1 rs1799750 genotypes may be indirectly involved in carcinogenesis. The detailed mechanisms of how MMP-1 rs1799750 genotypes interact with other molecules leading to CRC need further investigation. One possible explanation is that MMP-1 rs1799750 2G/2G genotype may elevate the transcriptional activity of MMP-1, leading to a higher expression of MMP-1 in the tissue, which activates the breakdown of collagens (23). The possible mechanism make sense that the 1G/1G genotype at MMP-1 rs1799750 may be associated with a lower risk of local lymph node metastasis (Table VI).

There were so many environmental or clinical factors involved in CRC risk, such as age, gender, familial CRC history, diet, alcohol consumption, and obesity, tumor site, size, grade, histologic type, TNM stage, and carcinoembryonic antigen (CEA) level, and they all have been reported to affect the overall survival of CRC patients (36-39). But the study is conducted form the viewpoint of epidemiology and lack of genetic data. In the current study, we combined the demographic data, in addition to clinical-pathological records, with genotyping data and reported that MMP-1 rs1799750 1G/1G genotypes interacted with non-smoking (Table IV) and non-alcohol drinking habits (Table V) to influence the CRC risk. However, the etiology of how MMP-1 rs1799750 1G/1G genotypes interacted with non-smoking and non-alcohol drinking habits to influence the CRC risk needs further investigation.

In conclusion, we provided evidence for the association of polymorphisms at MMP-1 rs1799750 with CRC risk. Our results suggest that the 1G/2G and 1G/1G genotypes of the rs1799750 confer personal susceptibility to risk among Taiwanese. These polymorphisms may also serve as predictors for better prognosis, such as lower rate of metastasis.

Acknowledgements

The Authors are grateful to Yu-Chen Hsiau, Yu-Ting Chin and Tai-Lin Huang for their excellent technical assistance. All the participants including those who were not selected into the control group of the study are appreciated. This study was supported mainly by Taichung Armed Forces General Hospital (grant number: TCAFGH-D-109018). The funders had no role in study design, data collection, statistical analysis, or decision to publish or preparation of the manuscript.

Footnotes

  • * These Authors contributed equally to the study.

  • ↵Authors’ Contributions

    Research design: Wu MH, Yueh TC and Chang WS; patient and questionnaire summaries: Wu MH, Yueh TC and Yang MD; experimental work: Chang WS and Tsai CW; statistical analysis: Fu CK and Yu CC; article writing: Tsai CW and Bau DT; review and revision: Bau DT.

  • This article is freely accessible online.

  • Conflicts of Interest

    The Authors have declared no conflicts of interest regarding this study.

  • Received January 19, 2021.
  • Revision received February 4, 2021.
  • Accepted February 15, 2021.
  • Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Siegel RL,
    2. Miller KD and
    3. Jemal A
    : Cancer statistics, 2019. CA Cancer J Clin 69(1): 7-34, 2019. PMID: 30620402. DOI: 10.3322/caac.21551
    OpenUrlCrossRefPubMed
  2. ↵
    1. Arnold M,
    2. Sierra MS,
    3. Laversanne M,
    4. Soerjomataram I,
    5. Jemal A and
    6. Bray F
    : Global patterns and trends in colorectal cancer incidence and mortality. Gut 66(4): 683-691, 2017. PMID: 26818619. DOI: 10.1136/gutjnl-2015-310912
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Siegel RL,
    2. Torre LA,
    3. Soerjomataram I,
    4. Hayes RB,
    5. Bray F,
    6. Weber TK and
    7. Jemal A
    : Global patterns and trends in colorectal cancer incidence in young adults. Gut 68(12): 2179-2185, 2019. PMID: 31488504. DOI: 10.1136/gutjnl-2019-319511
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Douaiher J,
    2. Ravipati A,
    3. Grams B,
    4. Chowdhury S,
    5. Alatise O and
    6. Are C
    : Colorectal cancer-global burden, trends, and geographical variations. J Surg Oncol 115(5): 619-630, 2017. PMID: 28194798. DOI: 10.1002/jso.24578
    OpenUrlCrossRef
  5. ↵
    1. Nagini S
    : Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol 4(7): 156-69, 2012. PMID: 22844547. DOI: 10.4251/wjgo.v4.i7.156
    OpenUrlCrossRefPubMed
  6. ↵
    1. Jayasurya R,
    2. Sathyan KM,
    3. Lakshminarayanan K,
    4. Abraham T,
    5. Nalinakumari KR,
    6. Abraham EK,
    7. Nair MK and
    8. Kannan S
    : Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma. Mod Pathol 18(8): 1056-1066, 2005. PMID: 15731778. DOI: 10.1038/modpathol.3800387
    OpenUrlCrossRefPubMed
  7. ↵
    1. Butterworth AS,
    2. Higgins JP and
    3. Pharoah P
    : Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 42(2): 216-227, 2006. PMID: 16338133. DOI: 10.1016/j.ejca.2005.09.023
    OpenUrlCrossRefPubMed
  8. ↵
    1. Houlston RS and
    2. Tomlinson IP
    : Polymorphisms and colorectal tumor risk. Gastroenterology 121(2): 282-301, 2001. PMID: 11487538. DOI: 10.1053/gast.2001.26265
    OpenUrlCrossRefPubMed
  9. ↵
    1. Wu MH,
    2. Tzeng HE,
    3. Wu CN,
    4. Yueh TC,
    5. Peng YC,
    6. Tsai CH,
    7. Wang YC,
    8. Ke TW,
    9. Pei JS,
    10. Chang WS,
    11. Tsai CW and
    12. Bau DT
    : Association of matrix metalloproteinase-9 rs3918242 promoter genotypes with colorectal cancer risk. Anticancer Res 39(12): 6523-6529, 2019. PMID: 31810917. DOI: 10.21873/anticanres.13867
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Wu MH,
    2. Hung YW,
    3. Gong CL,
    4. Chao CC,
    5. Yueh TC,
    6. Wang SC,
    7. Lai YL,
    8. Hsu SW,
    9. Fu CK,
    10. Wang YC,
    11. Ke TW,
    12. Chang WS,
    13. Tsai CW and
    14. Bau DT
    : Contribution of caspase-8 genotypes to colorectal cancer risk in taiwan. Anticancer Res 39(6): 2791-2797, 2019. PMID: 31177115. DOI: 10.21873/anticanres.13406
    OpenUrlAbstract/FREE Full Text
    1. Yueh TC,
    2. Hung YW,
    3. Shih TC,
    4. Wu CN,
    5. Wang SC,
    6. Lai YL,
    7. Hsu SW,
    8. Wu MH,
    9. Fu CK,
    10. Wang YC,
    11. Ke TW,
    12. Chang WS,
    13. Tsai CW and
    14. Bau DT
    : Contribution of murine double minute 2 genotypes to colorectal cancer risk in taiwan. Cancer Genomics Proteomics 15(5): 405-411, 2018. PMID: 30194081. DOI: 10.21873/cgp.20099
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Yueh TC,
    2. Wu CN,
    3. Hung YW,
    4. Chang WS,
    5. Fu CK,
    6. Pei JS,
    7. Wu MH,
    8. Lai YL,
    9. Lee YM,
    10. Yen ST,
    11. Li HT,
    12. Tsai CW and
    13. Bau DT
    : The contribution of MMP-7 genotypes to colorectal cancer susceptibility in Taiwan. Cancer Genomics Proteomics 15(3): 207-212, 2018. PMID: 29695403. DOI: 10.21873/cgp.20079
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Hung YC,
    2. Chang WS,
    3. Chou AK,
    4. Pei JS,
    5. Yang MD,
    6. Yang HR,
    7. Yang TM,
    8. Wang YC,
    9. Hsiau YC,
    10. Chen CP,
    11. Chen CC,
    12. Yu CC,
    13. Tsai CW and
    14. Bau DT
    : Association of adiponectin genotypes with colorectal cancer susceptibility in Taiwan. Anticancer Res 40(3): 1297-1306, 2020. PMID: 32132026. DOI: 10.21873/anticanres.14071
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. de Souza AP,
    2. Trevilatto PC,
    3. Scarel-Caminaga RM,
    4. Brito RB and
    5. Line SR
    : MMP-1 promoter polymorphism: association with chronic periodontitis severity in a Brazilian population. J Clin Periodontol 30(2): 154-158, 2003. PMID: 12622858. DOI: 10.1034/j.1600-051x.2003.300202.x
    OpenUrlCrossRefPubMed
  14. ↵
    1. Egeblad M and
    2. Werb Z
    : New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3): 161-174, 2002. PMID: 11990853. DOI: 10.1038/nrc745
    OpenUrlCrossRefPubMed
  15. ↵
    1. Van Lint P and
    2. Libert C
    : Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 82(6): 1375-1381, 2007. PMID: 17709402. DOI: 10.1189/jlb.0607338
    OpenUrlCrossRefPubMed
  16. ↵
    1. Liao CH,
    2. Wu HC,
    3. Hu PS,
    4. Hsu SW,
    5. Shen TC,
    6. Hsia TC,
    7. Chang WS,
    8. Tsai CW and
    9. Bau DT
    : The association of matrix metalloproteinase-1 promoter polymorphisms with prostate cancer in taiwanese patients. Anticancer Res 38(7): 3907-3911, 2018. PMID: 29970511. DOI: 10.21873/anticanres.12675
    OpenUrlAbstract/FREE Full Text
    1. Shen TC,
    2. Chang WS,
    3. Tsai CW,
    4. Chao CY,
    5. Lin YT,
    6. Hsiao CL,
    7. Hsu CL,
    8. Chen WC,
    9. Hsia TC and
    10. Bau DT
    : The contribution of matrix metalloproteinase-1 promoter genotypes in Taiwan lung cancer risk. Anticancer Res 38(1): 253-257, 2018. PMID: 29277780. DOI: 10.21873/anticanres.12215
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Tsai CB,
    2. Hsia NY,
    3. Wang YC,
    4. Wang ZH,
    5. Chin YT,
    6. Huang TL,
    7. Yu CC,
    8. Chang WS,
    9. Tsai CW,
    10. Yin MC and
    11. Bau DT
    : The significant association of MMP-1 genotypes with Taiwan pterygium. Anticancer Res 40(2): 703-707, 2020. PMID: 32014911. DOI: 10.21873/anticanres.14000
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Chen GL,
    2. Shen TC,
    3. Chang WS,
    4. Tsai CW,
    5. Li HT,
    6. Chuang CL,
    7. Lai YL,
    8. Yueh TC,
    9. Hsia TC,
    10. Wang SC and
    11. Bau DT
    : The contribution of MMP-7 promoter polymorphisms to Taiwan lung cancer susceptibility. Anticancer Res 38(10): 5671-5677, 2018. PMID: 30275186. DOI: 10.21873/anticanres.12903
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Pendás AM,
    2. Santamaría I,
    3. Alvarez MV,
    4. Pritchard M and
    5. López-Otín C
    : Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. Genomics 37(2): 266-268, 1996. PMID: 8921407. DOI: 10.1006/geno.1996.0557
    OpenUrlCrossRefPubMed
  20. ↵
    1. Goldberg GI,
    2. Wilhelm SM,
    3. Kronberger A,
    4. Bauer EA,
    5. Grant GA and
    6. Eisen AZ
    : Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261(14): 6600-6605, 1986. PMID: 3009463
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Tower GB,
    2. Coon CI and
    3. Brinckerhoff CE
    : The 2G single nucleotide polymorphism (SNP) in the MMP-1 promoter contributes to high levels of MMP-1 transcription in MCF-7/ADR breast cancer cells. Breast Cancer Res Treat 82(2): 75-82, 2003. PMID: 14692651. DOI: 10.1023/B:BREA.0000003948.14026.7c
    OpenUrlCrossRefPubMed
  22. ↵
    1. Liu D,
    2. Guo H,
    3. Li Y,
    4. Xu X,
    5. Yang K and
    6. Bai Y
    : Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. PLoS One 7(2): e31251, 2012. PMID: 22348060. DOI: 10.1371/journal.pone.0031251
    OpenUrlCrossRefPubMed
  23. ↵
    1. Huang Z,
    2. Yang Q and
    3. Huang Z
    : Identification of critical genes and five prognostic biomarkers associated with colorectal cancer. Med Sci Monit 24: 4625-4633, 2018. PMID: 29973580. DOI: 10.12659/MSM.907224
    OpenUrlCrossRef
    1. Hozhabri H,
    2. Lashkari A,
    3. Razavi SM and
    4. Mohammadian A
    : Integration of gene expression data identifies key genes and pathways in colorectal cancer. Med Oncol 38(1): 7, 2021. PMID: 33411100. DOI: 10.1007/s12032-020-01448-9
    OpenUrlCrossRef
  24. ↵
    1. Chen L,
    2. Lu D,
    3. Sun K,
    4. Xu Y,
    5. Hu P,
    6. Li X and
    7. Xu F
    : Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Gene 692: 119-125, 2019. PMID: 30654001. DOI: 10.1016/j.gene.2019.01.001
    OpenUrlCrossRef
  25. ↵
    1. Pei JS,
    2. Hsu PC,
    3. Chou AK,
    4. Tsai CW,
    5. Chang WS,
    6. Hsiao CL,
    7. Hsu YN,
    8. Cheng SP and
    9. Bau DT
    : Matrix metalloproteinase-1 genotype contributes to the risk of non-solid tumor in childhood leukemia. Anticancer Res 36(10): 5127-5132, 2016. PMID: 27798872. DOI: 10.21873/anticanres.11082
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Devulapalli K,
    2. Bhayal AC,
    3. Porike SK,
    4. Macherla R,
    5. Akka J,
    6. Nallari P and
    7. Ananthapur V
    : Role of interstitial collagenase gene promoter polymorphism in the etiology of gastric cancer. Saudi J Gastroenterol 20(5): 309-314, 2014. PMID: 25253367. DOI: 10.4103/1319-3767.141693
    OpenUrlCrossRef
  27. ↵
    1. Tsai CW,
    2. Chang WS,
    3. Gong CL,
    4. Shih LC,
    5. Chen LY,
    6. Lin EY,
    7. Li HT,
    8. Yen ST,
    9. Wu CN and
    10. Bau DT
    : Contribution of matrix metallopeptidase-1 genotypes, smoking, alcohol drinking and areca chewing to nasopharyngeal carcinoma susceptibility. Anticancer Res 36(7): 3335-40, 2016. PMID: 27354591
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Peng B,
    2. Cao L,
    3. Wang W,
    4. Xian L,
    5. Jiang D,
    6. Zhao J,
    7. Zhang Z,
    8. Wang X and
    9. Yu L
    : Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies. Mutagenesis 25(1): 41-48, 2010. PMID: 19843588. DOI: 10.1093/mutage/gep041
    OpenUrlCrossRefPubMed
  29. ↵
    1. Zhou H and
    2. Zhu X
    : Association between matrix-metalloproteinase polymorphisms and prostate cancer risk: a meta-analysis and systematic review. Cancer Manag Res 10: 5247-5259, 2018. PMID: 30464622. DOI: 10.2147/CMAR.S177551
    OpenUrlCrossRef
    1. Zhu XM and
    2. Sun WF
    : Association between matrix metalloproteinases polymorphisms and ovarian cancer risk: A meta-analysis and systematic review. PLoS One 12(9): e0185456, 2017. PMID: 28957437. DOI: 10.1371/journal.pone.0185456
    OpenUrlCrossRef
    1. Wang L and
    2. Kong B
    : Analysis of the association of matrix metalloproteinase-1 gene promoter (rs1799750) polymorphism and risk of ovarian cancer. Int J Gynecol Cancer 25(6): 961-967, 2015. PMID: 25950130. DOI: 10.1097/IGC.0000000000000463
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Hsiao CL,
    2. Liu LC,
    3. Shih TC,
    4. Lai YL,
    5. Hsu SW,
    6. Wang HC,
    7. Pan SY,
    8. Shen TC,
    9. Tsai CW,
    10. Chang WS,
    11. Su CH,
    12. Way TD,
    13. Chung JG and
    14. Bau DT
    : The association of Matrix Metalloproteinase-1 promoter polymorphisms with breast cancer. In Vivo 32(3): 487-491, 2018. PMID: 29695550. DOI: 10.21873/invivo.11265
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Chen PC,
    2. Lee JC and
    3. Wang JD
    : Estimation of life-year loss and lifetime costs for different stages of colon adenocarcinoma in taiwan. PLoS One 10(7): e0133755, 2015. PMID: 26207912. DOI: 10.1371/journal.pone.0133755
    OpenUrlCrossRef
    1. Beckmann KR,
    2. Bennett A,
    3. Young GP,
    4. Cole SR,
    5. Joshi R,
    6. Adams J,
    7. Singhal N,
    8. Karapetis C,
    9. Wattchow D and
    10. Roder D
    : Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study. BMC Health Serv Res 16: 24, 2016. PMID: 26792195. DOI: 10.1186/s12913-016-1263-3
    OpenUrlCrossRef
    1. Perron L,
    2. Daigle JM,
    3. Vandal N,
    4. Guertin MH and
    5. Brisson J
    : Characteristics affecting survival after locally advanced colorectal cancer in Quebec. Curr Oncol 22(6): e485-492, 2015. PMID: 26715887. DOI: 10.3747/co.22.2692
    OpenUrlCrossRef
  32. ↵
    1. Wang R,
    2. Wang MJ and
    3. Ping J
    : Clinicopathological features and survival outcomes of colorectal cancer in young versus elderly: A population-based cohort study of SEER 9 registries data (1988-2011). Medicine (Baltimore) 94(35): e1402, 2015. PMID: 26334895. DOI: 10.1097/MD.0000000000001402
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Cancer Genomics - Proteomics: 18 (3)
Cancer Genomics & Proteomics
Vol. 18, Issue 3
May-June 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Contribution of Matrix Metalloproteinase-1 Genotypes to Colorectal Cancer in Taiwan
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Contribution of Matrix Metalloproteinase-1 Genotypes to Colorectal Cancer in Taiwan
MING-HSIEN WU, TE-CHENG YUEH, WEN-SHIN CHANG, CHIA-WEN TSAI, CHUN-KAI FU, MEI-DUE YANG, CHIEN-CHIH YU, DA-TIAN BAU
Cancer Genomics & Proteomics May 2021, 18 (3) 245-251; DOI: 10.21873/cgp.20255

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Contribution of Matrix Metalloproteinase-1 Genotypes to Colorectal Cancer in Taiwan
MING-HSIEN WU, TE-CHENG YUEH, WEN-SHIN CHANG, CHIA-WEN TSAI, CHUN-KAI FU, MEI-DUE YANG, CHIEN-CHIH YU, DA-TIAN BAU
Cancer Genomics & Proteomics May 2021, 18 (3) 245-251; DOI: 10.21873/cgp.20255
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Contribution of Interleukin-12A Genotypes to Breast Cancer Risk
  • Association of Matrix Metalloproteinase-1 Genotypes With Bladder Cancer Risk
  • The Association of MMP9 Promoter Rs3918242 Genotype With Gastric Cancer
  • Google Scholar

More in this TOC Section

  • Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases
  • The Contribution of PDCD6 Polymorphisms to Oral Cancer Risk
  • Requirement of CLIC4 Expression in Human Colorectal Cancer Cells for Sensitivity to Growth Inhibition by Fucoxanthinol
Show more Article

Similar Articles

Keywords

  • Colorectal cancer
  • genotype
  • MMP-1
  • polymorphism
  • Taiwan
Cancer & Genome Proteomics

© 2022 Cancer Genomics & Proteomics

Powered by HighWire